Authors


David Fischer, MD

Latest:

Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD

The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]


Douglas Scharre, MD

Latest:

Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD

Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]


Mitzi Joi Williams, MD

Latest:

Medical Gaslighting: Multiple Sclerosis’ Dirty Little Secret?

The effect of gaslighting on patients can result in serious harms, and although it is potentially common in the MS care continuum, whether it is deliberate or an institutional problem, it must be called out by providers.


Carl Gold, MD, MS

Latest:

AUPN Leadership Minute Episode 35: Building a High-Quality QI Program

Episode 35 of the AUPN Leadership Minute features Tracey A. Milligan, MD, of New York Medical College; and Carl Gold, MD, MS, of Stanford University. [WATCH TIME: 5 minutes]


Debra Davis, CRNP

Latest:

Advice for Advanced Practice Providers in Managing Sleep Disorders

Advanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.


Indu Subramanian, MD

Latest:

AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]


Blake Buletko, MD

Latest:

Lessons Learned From Cleveland Clinic’s Mobile Stroke Unit: Blake Buletko, MD

The vascular neurologist and director of the residency program at Cleveland Clinic provided perspective on the biggest learning experiences over the past decade for Cleveland Clinic’s mobile stroke unit. [WATCH TIME: 4 minutes]


Mina Lobbous, MD, MPH

Latest:

Innovations in Glioblastoma Research

Glioblastoma, a highly aggressive brain cancer, presents substantial treatment challenges necessitating innovative therapies and interdisciplinary research to improve patient outcomes.


David Z. Rose, MD

Latest:

Cost-Effective Detection of Poststroke Atrial Fibrillation Identified in STROKE-AF Trial: David Z. Rose, MD

The professor of neurology at University of South Florida talked about the cost-effectiveness of insertable cardiac monitors to detect new atrial fibrillation in patients with large-artery or small-vessel disease stroke. [WATCH TIME: 4 minutes]


Michael Levy, MD, PhD

Latest:

Balancing Efficacy, Safety, and Cost When Deciding Treatment Options for NMOSD: Michael Levy, MD, PhD

The associate professor of neurology at Harvard Medical School discussed how clinicians face the challenging decision with their patients in choosing between off-label and approved medications for NMOSD. [WATCH TIME: 4 minutes]


Deepti Zutshi, MD, FAAN

Latest:

Expensive Antiseizure Medications Cause for Concern for Patients with Epilepsy: Deepti Zutshi, MD, FAAN

The associate professor of neurology at Wayne State University in Detroit, Michigan, spoke about expensive antiseizure medications for epilepsy along with spending for Medicare and Medicaid at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]


Clifton L. Gooch, MD

Latest:

AUPN Leadership Minute Episode 40: Funding Resident and Fellow Positions

Episode 40 of the AUPN Leadership Minute features Clifton L. Gooch, MD, of the University of South Florida; and Tom Frontera, MD, of the University of South Florida. [WATCH TIME: 9 minutes]


Marcia Morita-Sherman, MD, PhD

Latest:

Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?


Thomas Topley, MBA

Latest:

The Mobile Stroke Unit Paradigm Shift for EMS: Thomas Topley

The executive director of the Bensalem Rescue Squad spoke specifically to how the MSU has shifted the paradigm of care that EMS can provide to individuals in the community. [WATCH TIME: 4 minutes]


Glenn Graham, MD, PhD

Latest:

AUPN 2022 Veterans Health Administration Workshop

Glenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]


Michael Weiner, MD

Latest:

Advancements in the Alzheimer Disease Field: Michael Weiner, MD

The director of the Brain Health Registry discussed advancements in AD, following the publication of a systematic review on the predictors of Aß.


Lawrence Elmer, MD, PhD

Latest:

Remaining Questions and Next Steps for Parkinson Agent P2B001: Lawrence Elmer, MD, PhD; Cheryl Fitzer-Attas, PhD

The medical director of the Center for Neurological Disorders at the University of Toledo discussed positive phase 3 findings assessing P2B001, and how the agent would potentially fit in the Parkinson treatment landscape. [WATCH TIME: 4 minutes]


Rachelle S. Doody, MD, PhD

Latest:

Roche’s NeuroToolKit in Alzheimer Disease Research: Rachelle S. Doody, MD, PhD

The global head of Neurodegeneration at Roche/Genentech shared insight into the development of the company’s NeuroToolKit and its use in its Alzheimer disease research.


Bryan Walker, MHS, PA-C

Latest:

Managing MS in the Community: Advice and Resources

Advice and resources for colleagues, including community practitioners and neurologists, to encourage collaboration and best support for patients with multiple sclerosis (MS).


Russell Cerejo, MD

Latest:

Rehab Process and Need for Improved Guidelines of Basilar Artery Occlusions: Russell Cerejo, MD

The vascular neurologist at Allegheny Health Network provided insight on the need to create consensus guidelines that further explain the treatment, management, and rehab of basilar artery occlusions. [WATCH TIME: 3 minutes]


Salima Brillman, MD

Latest:

A Multifaceted Approach to Understanding ON and OFF Periods in Parkinson Disease: Salima Brillman, MD

At AMTRD 2023, the movement disorder neurologist at the Parkinson’s Disease and Movement Disorder Center of Silicon Valley talked about the current care landscape for Parkinson disease and improving on-time for patients experiencing OFF periods. [WATCH TIME: 5 minutes]


Richard C. Burgess, MD, PhD

Latest:

The Current State and Future Promise of Magnetoencephalography (MEG) in Epilepsy and Beyond

Magnetoencephalography provides an opportunity for physicians to capture a more dynamic view of brain function over time and space that may offer an advantage to clinical care.


Carolyn Bernstein, MD

Latest:

Integrative and Alternative Patient-Centered Therapies in Neurology: Carolyn Bernstein, MD

The assistant professor of neurology at Harvard Medical School talked about integrative therapies that may offer promising alternatives to traditional treatments for aiding neurological conditions. [WATCH TIME: 5 minutes]


Dilesh Doshi, PharmD

Latest:

Reassessing Treatment Options, Quetiapine for Parkinson Disease Psychosis: Dilesh Doshi, PharmD

The vice president of Health Economic and Outcomes Research at Acadia Pharmaceuticals provided perspective on the negative effects seen from quetiapine and how the knowledge of pimavanserin has improved since approval. [WATCH TIME: 5 minutes]


Lars Alfredsson, PhD

Latest:

Association Between Obesity and Disease Progression in Multiple Sclerosis: Lars Alfredsson, PhD

The professor of epidemiology at Karolinska Institutet talked about findings from a comprehensive study on the correlation between obesity and accelerated progression of multiple sclerosis. [WATCH TIME: 8 minutes]


Gina Mavrikis Cox, PhD

Latest:

The Role of Serum Biomarkers in the Management of MS

Jason Freeman, MD, MBA, and Gina Mavrikis Cox, PhD, discuss a presentation from CMSC 2023 on the role of serum biomarkers in multiple sclerosis management. Sponsored by Novartis.


Ludwig A. Kappos, MD

Latest:

Predicting Patient Response to MS Treatment Using Cognitive Outcome Measures: Ludwig Kappos, MD, FEAN, FAAN

The professor of neurology at the University of Basel provided insight on a new methodology that allows depiction of patient profiles from baseline characteristics and their associations with individual outcomes. [WATCH NOW: 5 minutes]


Vijayshree Yadav, MD, MCR, FANA, FAAN

Latest:

Investigating the Impact of a Low-Fat Diet on Quality of Life and Symptom Management in MS: Vijayshree Yadav, MD, MCR, FANA, FAAN

The professor of neurology at Oregon Health & Science University talked about a study on a modified low-fat diet intervention and its effects on fatigue in patients with multiple sclerosis over a 16-week period at CMSC 2023. [WATCH TIME: 8 minutes]


Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

Latest:

Head-of-Bed Positioning Impact on Patients' Recovery Following Thrombectomy: Anne W. Alexandrov PhD, RN, CCRN, ANVP-BC, NVRN-BC, FAAN

The professor of nursing and neurology at the University of Tennessee Health Science Center talked about findings from a study investigating head-of-bed position in patients undergoing thrombectomy which was presented at ISC 2024. [WATCH TIME: 6 minutes]


Richard Bogan, MD, FCCP, FAASM

Latest:

Final Advice for Clinicians Treating Narcolepsy

Drs Thorpy, Dogan, Doghramji, and Kushida share clinical pearls for primary care providers who are taking care of patients with narcolepsy.

© 2024 MJH Life Sciences

All rights reserved.